Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN

NCT05755386 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

106

Enrollment

INDUSTRY

Sponsor class

Conditions

IC-MPGN

Interventions

DRUG: Placebo
DRUG: iptacopan

Sponsor

Novartis Pharmaceuticals